Oncology & Cancer

Immunotherapy shows promise in preventing leukemia relapse

Fred Hutchinson Cancer Research Center announced promising results from an early trial in which patients with high-risk acute myeloid leukemia received genetically engineered immune cells. Of the 12 AML patients who received ...

Diseases, Conditions, Syndromes

Preventative antibiotics could prevent C. diff in transplant patients

It may be possible to safely prevent one of the most common - and costly to treat - infections contracted by hospitalized patients undergoing bone marrow transplantation for the treatment of blood cancers, according to a ...

Medical research

Tackling blood diseases, immune disorders

Harvard University has completed a license agreement with Magenta Therapeutics, a new startup company launched in Cambridge, for a portfolio of technologies with the potential to transform blood stem cell transplants from ...

page 28 from 40